NCT05416320Early phase 1Withdrawn
Calcipotriol as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)
A Pilot Study of Calcipotriol as a Novel Treatment for Central Centrifugal Cicatricial Alopecia
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Withdrawn
- Declared phase
- Early phase 1
- Sponsor
- Wake Forest University Health Sciences
- Participants (registry)
- —
- Start
- August 2023 (planned)
- Primary completion
- November 2023
- Study completion
- December 2023
- Last registry update
- August 2023
- Countries
- United States
Conditions studied: Central Centrifugal Cicatricial Alopecia
Interventions: Calcipotriol, Dovonex, Subject's already prescribed drug
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.